Rameswari Chilamakuri

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Papillary Thyroid

Top Venues

Current oncology (Toronto, Ont.)

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Vineela Parvathaneni, Rameswari Chilamakuri, Nishant S Kulkarni, Nabeela F Baig, Saurabh Agarwal, Vivek Gupta
Exploring Amodiaquine's Repurposing Potential in Breast Cancer Treatment-Assessment of In-Vitro Efficacy & Mechanism of Action. International journal of molecular sciences 23 (19) (2022)
Rameswari Chilamakuri, Danielle Crystal Rouse, Saurabh Agarwal
Inhibition of Polo-like Kinase 1 by HMN-214 Blocks Cell Cycle Progression and Inhibits Neuroblastoma Growth. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Rameswari Chilamakuri, Saurabh Agarwal
Direct Targeting of the Raf-MEK-ERK Signaling Cascade Inhibits Neuroblastoma Growth. Current oncology (Toronto, Ont.) 29 (9) (2022)
Rameswari Chilamakuri, Saurabh Agarwal
Dual Targeting of PI3K and HDAC by CUDC-907 Inhibits Pediatric Neuroblastoma Growth. Cancers 14 (4) (2022)